These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34185284)

  • 1. Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.
    Macha MA; Wani NA; Ganai RA; Bhat AA; Hamid A; Hashem S; Haris M; Chauhan SS; Zargar MA; Batra SK
    Adv Exp Med Biol; 2020; 1296():11-31. PubMed ID: 34185284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
    Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
    Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment.
    Zhang Y; Dong P; Yang L
    Front Immunol; 2023; 14():1189323. PubMed ID: 37292204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
    Zhu D; He X; Li Y; Li G; Chen M
    Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck cancer: Current challenges and future perspectives.
    Bhat GR; Hyole RG; Li J
    Adv Cancer Res; 2021; 152():67-102. PubMed ID: 34353444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.
    Hanoteau A; Newton JM; Krupar R; Huang C; Liu HC; Gaspero A; Gartrell RD; Saenger YM; Hart TD; Santegoets SJ; Laoui D; Spanos C; Parikh F; Jayaraman P; Zhang B; Van der Burg SH; Van Ginderachter JA; Melief CJM; Sikora AG
    J Immunother Cancer; 2019 Jan; 7(1):10. PubMed ID: 30646957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.
    Bhat AA; Yousuf P; Wani NA; Rizwan A; Chauhan SS; Siddiqi MA; Bedognetti D; El-Rifai W; Frenneaux MP; Batra SK; Haris M; Macha MA
    Signal Transduct Target Ther; 2021 Jan; 6(1):12. PubMed ID: 33436555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The tumor microenvironment-relay station for prognosis and therapy response].
    Krupar R
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):141-147. PubMed ID: 36414699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immune microenvironment in head and neck cancers.
    Chen SMY; Krinsky AL; Woolaver RA; Wang X; Chen Z; Wang JH
    Mol Carcinog; 2020 Jul; 59(7):766-774. PubMed ID: 32017286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck cancer treatment in the era of molecular medicine.
    Pandruvada S; Kessler R; Thai A
    Adv Cancer Res; 2023; 160():205-252. PubMed ID: 37704289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC.
    Gong X; Xiong J; Gong Y; Zhang J; Zhang J; Yang G; Chi H; Tian G
    Front Immunol; 2023; 14():1275270. PubMed ID: 37876923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The head and neck cancer genome in the era of immunotherapy.
    Wijetunga NA; Yu Y; Morris LG; Lee N; Riaz N
    Oral Oncol; 2021 Jan; 112():105040. PubMed ID: 33197752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Immunology and HPV.
    Wollenberg B
    Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling.
    Raudenska M; Balvan J; Hanelova K; Bugajova M; Masarik M
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188940. PubMed ID: 37331641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
    Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
    Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
    Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
    Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.